CHICAGO – High drug costs and drug shortages negatively impact both patients and prescribing physicians, but encouraging market competition and education regarding cost differentials can lessen those impacts, according to a speaker here.
A study comparing outcomes in latanoprost patients before and after a generic version became available found that those who continued to use the brand name version were 29% less likely to have improved adherence and 39% more likely to have reduced adherence, Joshua D. Stein, MD, MS, said at Glaucoma Subspecialty Day preceding the American Academy of
Uncategorized